Policymakers are exploring reforms to address shortcomings of risk adjustment that inflate Medicare Advantage payments and ...

Background: Despite therapeutic advancements, asthma exacerbations (AEs) remain a major clinical challenge, with immune-inflammatory patterns incompletely characterized. Current guidelines lack robust ...

A recall of cheese products sold by Aldi due potential contamination with metal fragments has been given the second-highest risk warning by the U.S. Food and Drug Administration (FDA). Great Lakes ...

Compared with unexposed pregnancies, the GLP-1 RA-exposed group had a higher risk for preterm delivery, gestational diabetes, and hypertensive disorders of pregnancy. HealthDay News — Glucagon-like ...

Compared with unexposed pregnancies, the GLP-1 RA group had a higher risk for excess gestational weight gain, and a higher risk for preterm delivery, gestational diabetes, and hypertensive disorders ...

Introduction: Adverse events associated with antidepressants may contribute to stigma, morbidity, and suicidal behaviour among patients. Effectively assessing the risk of potential AEs induced by ...

In a major new study, researchers from Intermountain Health in Salt Lake City have found that weight loss drugs used by patients who have high triglycerides do not increase their risk of pancreatitis ...

THOUSAND OAKS, Calif., Nov. 8, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced detailed results from the Phase 3 VESALIUS-CV clinical trial, which showed that Repatha® (evolocumab) achieved ...

The presence of acute kidney injury (AKI) during pregnancy was associated with a higher risk for adverse cardiovascular and renal outcomes. Researchers conducted a systematic review and meta-analysis ...

A new study of a UK-based birth cohort highlights the long-term health consequences of adverse childhood experiences, particularly a heightened risk for severe pain and poor mental health. Adverse ...

As Department of Health and Human Services (HHS) and FDA leadership continue to look for ways to boost transparency and reshape the U.S' healthcare infrastructure, the U.S. drug regulator has unveiled ...